Literature DB >> 18998197

Effect of octreotide on postmenopausal hot flushes.

Robert D Hoeldtke1, Kimberly D Bryner, Hugh C Palmer, Lori Eddy, Linda Stark, Gerald Hobbs.   

Abstract

We have previously documented that octreotide therapy suppresses sweating and palpitations in patients with the postural tachycardia syndrome. We now report that octreotide also suppresses these and related symptoms in patients with postmenopausal hot flushes.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18998197     DOI： 10.1007/s10286-008-0503-y

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


  5 in total

1.  Hot-flash hypotension.

Authors:  Richard Nelesen; Pattie Krohn; Joel E Dimsdale
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

2.  Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women.

Authors:  Y A Wyon; A C Spetz; G E Theodorsson; M L Hammar
Journal:  Menopause       Date:  2000 Jan-Feb       Impact factor: 2.953

3.  Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine.

Authors:  Robert D Hoeldtke; Kimberly D Bryner; Martin E Hoeldtke; Gerald Hobbs
Journal:  Clin Auton Res       Date:  2006-10-11       Impact factor: 4.435

4.  Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.

Authors:  S B Saslow; M D O'Brien; M Camilleri; M von der Ohe; H A Homburger; G G Klee; H C Pitot; J Rubin
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

5.  Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes.

Authors:  R R Freedman
Journal:  Fertil Steril       Date:  1998-08       Impact factor: 7.329
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.